NeutraSal (Supersaturated Calcium Phosphate Rinse)

Proven effective in treating oral mucositis1

Note: NeutraSal is not intended to prevent oral mucositis or xerostomia.

NeutraSal decreased the incidence of oral mucositis in patients undergoing chemotherapy (CT) and/or radiotherapy (RT)

  • 79-89% of patients reported favorable oral mucositis scores (Grade 0-2) after NeutraSal treatment
‡Oral mucositis scores were measured by the percentage of patients indicating Grade 0 (no adverse effects or within normal limits), Grade 1 (mild), or Grade 2 (moderate) symptom severity.
  • The incidence of severe mucositis in patients undergoing CT and/or RT (typically ranging from 34%-56%) was reduced to 11% with NeutraSal treatment§
  • 86% of patients reported they were satisfied or very satisfied with their NeutraSal treatment

Patients with head and neck cancer undergoing CT and/or RT (n=51) rinsed with NeutraSal 4 to 10 times a day for an average of 6 to 8 weeks.
§Severe oral mucositis was defined as Grades 3-4, as determined by World Health Organization's Oral Toxicity Score.

1. Dass K, Armstrong J, Goodwin J, et al. Efficacy of NeutraSal (Supersaturated Calcium Phosphate Rinse) in the Prevention and Treatment of Chemotherapy-induced or Radiotherapy-induced Oral Mucositis. ASTRO 2012 Study Registry Abstract; presented May 2012.

*Terms and Conditions: This offer is only valid for patients with commercial insurance where NeutraSal Supersaturated Calcium Phosphate Rinse is a covered medication. This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. By using this program, the patient agrees not to seek reimbursement for all or any part of the benefit received through this offer and is responsible for making any required reports of use of this offer to any insurer or other third party who pays any part of the prescription filled. This offer is good only in the United States of America (including the District of Columbia, Puerto Rico and the U.S. Virgin Islands). This offer is not valid where otherwise prohibited, taxed, or otherwise restricted and not valid for any person that is 65 years of age or older without commercial insurance. Patients must be 18 years of age or older to redeem this offer for themselves or a minor. This offer cannot be redeemed at government-subsidized clinics. This offer is valid for one (1) initial prescription fill of NeutraSal and up to ten (10) prescription refills. The maximum benefit available is $150 per box. Participating patients are responsible for all costs and expenses after the maximum benefit is reached. If the patient receives coverage through a health savings account (HSA) or similar arrangement, it is the patient’s responsibility to know how claims are processed and understand that amounts paid by the third party for their NeutraSal prescription may be deducted from their benefits limit automatically. This offer is not valid with other offers. The coupon has no cash value or cash back. This offer is not health insurance. This offer expires on December 31, 2016. Valeant Pharmaceuticals and OraPharma reserve the right to rescind, revoke, terminate, or amend this offer at any time, without notice.